Inovio Pharmaceuticals Inc (NASDAQ: INO) on Monday, plunged -5.92% from the previous trading day, before settling in for the closing price of $1.69. Within the past 52 weeks, INO’s price has moved between $1.30 and $2.98.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 22.92%. The company achieved an average annual earnings per share of 43.46%. With a float of $68.42 million, this company’s outstanding shares have now reached $68.70 million.
Inovio Pharmaceuticals Inc (INO) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Inovio Pharmaceuticals Inc is 0.42%, while institutional ownership is 40.93%.
Inovio Pharmaceuticals Inc (INO) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.6 earnings per share (EPS) for the period topping the consensus outlook (set at -0.83) by 0.23. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.55% during the next five years compared to 22.92% growth over the previous five years of trading.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Trading Performance Indicators
Inovio Pharmaceuticals Inc (INO) is currently performing well based on its current performance indicators. A quick ratio of 0.79 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 606.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.58, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.53 in one year’s time.
Technical Analysis of Inovio Pharmaceuticals Inc (INO)
Compared to the last year’s volume of 2.68 million, its volume of 3.05 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 5.46%.
During the past 100 days, Inovio Pharmaceuticals Inc’s (INO) raw stochastic average was set at 7.65%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1918 in the past 14 days, which was higher than the 0.1601 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.1026, while its 200-day Moving Average is $2.0001. Nevertheless, the first resistance level for the watch stands at $1.6767 in the near term. At $1.7633, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.8067. If the price goes on to break the first support level at $1.5467, it is likely to go to the next support level at $1.5033. Now, if the price goes above the second support level, the third support stands at $1.4167.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Key Stats
Market capitalization of the company is 109.24 million based on 66,730K outstanding shares. Right now, sales total 220 K and income totals -107,250 K. The company made 0 K in profit during its latest quarter, and -23,520 K in sales during its previous quarter.
